GeneFrontier Corp. logo — Accelerating Biopharmaceutical Advancements with Innovative...

GeneFrontier Corp.

Accelerating Biopharmaceutical Advancements with Innovative Antibody Technologies for Future Medical Breakthroughs

Founded 2010 2 employees Biotechnology, Care Economy +1

General Information

Company Name GeneFrontier Corp.
Founded Year 2010
Employees 2
Industries Biotechnology, Care Economy, Pharmaceutical
Social

Get notified when GeneFrontier Corp. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About GeneFrontier Corp.

GeneFrontier Corp. is a biopharmaceutical company with a focus on antibody technologies, aiming to revolutionize medical breakthroughs in the future. As a member of the Kaneka Group since October 2010, Gene Frontier has been a key player in the microarray and antibody-related sectors. In collaboration with MorphoSys, the company has ventured into the development of antibody drugs known for their precise targeting of disease-related proteins and reduced side effects. Leveraging artificial recombinant human antibody production technology, Gene Frontier is engaged in joint research and licensing initiatives to enhance antibody drug discovery within Japan. The company's commitment to accelerating biopharmaceutical research and development is poised to expand its business domains and capabilities in the field, with the support of Kaneka. Gene Frontier's alignment with Kaneka's vision of "To be more surprised, to Mirai" underscores its dedication to offering unique technologies and services for advancing innovative medicines and diagnostics, thus contributing to 21st-century medical treatments.

Taxonomy: Biopharmaceutical advancements, Antibody technologies, Drug discovery, Protein research, Research and development, Medical breakthroughs, Biotechnology collaboration, Innovative medicines, Diagnostic technologies, Global growth, Partnership with MorphoSys, Kaneka Group, Biopharmaceutical research, Business expansion, Corporate vision

No funding data available for GeneFrontier Corp. yet.

Get notified when GeneFrontier Corp. raises funding

GeneFrontier Corp. Alternatives & Competitors

GeneFrontier Corp. vs

Leading DNA/RNA synthesis innovator, delivering advanced synthetic genomics products for groundbreak...

Series B
13 employees
Biotechnology, Health Care
GeneFrontier Corp. vs

Pioneering advanced treatments for cancer with innovative therapeutic antibodies and drug conjugates...

Series D
Biotechnology, Health Care
GeneFrontier Corp. vs

an innovation-driven biopharmaceutical company dedicated to the discovery and development of innovat...

210 employees

FAQ About GeneFrontier Corp.

Accelerating Biopharmaceutical Advancements with Innovative Antibody Technologies for Future Medical Breakthroughs
GeneFrontier Corp. was founded in 2010.
GeneFrontier Corp. operates in the following industries: Biotechnology, Care Economy, Pharmaceutical.
GeneFrontier Corp. has approximately 2 employees.
Top alternatives and competitors to GeneFrontier Corp. include Tsingke Biotech, Agensys, Shanghai Junshi Biosciences Co Ltd, Bohai New Enzyme, Lyvgen Biopharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GeneFrontier Corp. and Tsingke Biotech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors GeneFrontier Corp. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy